| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NCPGASTHEP1235 |
| P698 | PubMed publication ID | 18797444 |
| P2093 | author name string | Wendy S Rubinstein | |
| Scott M Weissman | |||
| P2860 | cites work | Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability | Q24618618 |
| Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X | Q24618839 | ||
| The frequency of Muir-Torre syndrome among Lynch syndrome families | Q28268532 | ||
| Genetic testing and counseling for hereditary forms of colorectal cancer | Q33814001 | ||
| Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene | Q33904639 | ||
| An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome | Q33904733 | ||
| Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2 | Q33910123 | ||
| MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer | Q57200538 | ||
| Accuracy of Colorectal Polyp Self-Reports: Findings from the Colon Cancer Family Registry | Q57268364 | ||
| Inherited susceptibility to colorectal adenomas and carcinomas: Evidence for a new predisposition gene on 15q14-q22 | Q57742300 | ||
| Early Gastric Cancer in Young, Asymptomatic Carriers of Germ-Line E-Cadherin Mutations | Q59182691 | ||
| Keeping Pace with the Times — The Genetic Information Nondiscrimination Act of 2008 | Q60016790 | ||
| Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome | Q60167349 | ||
| Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas | Q61195948 | ||
| Progress in Genetic Testing, Classification, and Identification of Lynch Syndrome | Q62978207 | ||
| The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) | Q62978412 | ||
| Breast cancer susceptibility genes: current challenges and future promises | Q71086291 | ||
| Phenotypic and molecular characteristics of hyperplastic polyposis | Q74127278 | ||
| American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing | Q74139327 | ||
| MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers | Q74455966 | ||
| Practice parameters for the identification and testing of patients at risk for dominantly inherited colorectal cancer | Q74615205 | ||
| Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients | Q80050907 | ||
| Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients | Q80539040 | ||
| The "duty to warn" a patient's family members about hereditary disease risks | Q80597182 | ||
| Microsatellite instability is frequently observed in rectal cancer and influenced by neoadjuvant chemoradiation | Q80734818 | ||
| Molecular screening for the Lynch syndrome--better than family history? | Q81716567 | ||
| Hereditary colorectal cancer: risk assessment and management | Q34045183 | ||
| Deficient DNA mismatch repair: a common etiologic factor for colon cancer | Q34189020 | ||
| AGA technical review on hereditary colorectal cancer and genetic testing. | Q34299705 | ||
| A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). | Q34306976 | ||
| Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). | Q34557362 | ||
| Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers | Q35022384 | ||
| American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility | Q35105968 | ||
| Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer | Q35443388 | ||
| Attenuated familial adenomatous polyposis (AFAP). A review of the literature | Q35566208 | ||
| Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability | Q35747961 | ||
| The multiple colorectal adenoma phenotype and MYH, a base excision repair gene | Q35854432 | ||
| Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history | Q35895179 | ||
| Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review | Q35901489 | ||
| Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors | Q35986971 | ||
| Hereditary cancer predisposition syndromes | Q36002146 | ||
| The hamartomatous polyposis syndromes: a clinical and molecular review | Q36018533 | ||
| Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations | Q36338216 | ||
| Familial gastric polyposis revisited. Autosomal dominant inheritance confirmed | Q36384186 | ||
| Genetics, pathology, and clinics of familial gastric cancer | Q36406529 | ||
| The genetics of FAP and FAP-like syndromes | Q36602699 | ||
| Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review | Q36604730 | ||
| Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients | Q36890349 | ||
| Who should be sent for genetic testing in hereditary colorectal cancer syndromes? | Q36905417 | ||
| New issues in genetic counseling of hereditary colon cancer | Q37002381 | ||
| Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer | Q39582129 | ||
| Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect | Q41852209 | ||
| American founder mutation for attenuated familial adenomatous polyposis | Q42100555 | ||
| Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23 by genomewide high-density single nucleotide polymorphism (SNP) scan and identification of BMPR1A loss of function | Q43146864 | ||
| Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations | Q43915120 | ||
| Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families | Q46153060 | ||
| A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States | Q46655105 | ||
| Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management | Q47301537 | ||
| ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. | Q50789980 | ||
| Banning genetic discrimination. | Q52981673 | ||
| Hyperplastic polyposis and diffuse carcinoma of the stomach. A study of a family. | Q53479321 | ||
| Standards of care in diagnosis and testing for hereditary colon cancer. | Q54436204 | ||
| New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. | Q55033068 | ||
| The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. | Q55067670 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gastroenterology | Q120569 |
| P304 | page(s) | 569-582 | |
| P577 | publication date | 2008-09-16 | |
| P1433 | published in | Nature Reviews Gastroenterology & Hepatology | Q2108255 |
| P1476 | title | Managing hereditary gastrointestinal cancer syndromes: the partnership between genetic counselors and gastroenterologists | |
| P478 | volume | 5 |
| Q38106642 | 100 years Lynch syndrome: what have we learned about psychosocial issues? |
| Q38441095 | Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer |
| Q21261903 | Duodenal carcinoma at the ligament of Treitz. A molecular and clinical perspective |
| Q55717557 | Frontiers in Gastrointestinal Oncology: Advances in Multi-Disciplinary Patient Care. |
| Q42434480 | Signs and genetics of rare cancer syndromes with gastroenterological features |
| Q34081267 | The genetic basis of Lynch syndrome and its implications for clinical practice and risk management |
Search more.